Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma

Abstract excerpt

BACKGROUND: Cholangiocarcinoma (CCA) is a malignancy that originates from bile duct cells. The incidence and mortality of CCA are very high especially in Southeast Asian countries. Moreover, most CCA patients have a very poor outcome. Presently, there are still no effective treatment regimens for CCA. The resistance to several standard chemotherapy drugs occurs frequently; thus, searching for a novel effective...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Advanced Breast Cancer Therapies
• Share to Cholangiocarcinoma and Gallbladder Cancer Studies
• Share to Peptidase Inhibition and Analysis